Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
Thoracic Cancer|September 19, 2017
Proportion and characteristics of transient nodules in a retrospective analysis of pulmonary nodulesJin-Yeong Yu, Boram Lee, Sunmi Ju, et al.
Translational Lung Cancer Research|August 25, 2021
Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapyXuanye Zhang, Dan Tian, Yue Chen, et al.
Cells|May 13, 2023
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY TrialCheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, et al.
Cancers|February 10, 2024
Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung CancerHyeon Hwa Kim, Jae Cheol Lee, In-Jae Oh, et al.
Scientific Reports|October 23, 2023
Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancerHwa Kyung Park, Chang-Seok Yoon, Young-Ok Na, et al.
Thoracic Cancer|September 19, 2017
Prevalence of non-calcified pulmonary nodules in screening chest computed tomographySun Mi Ju, Hyun Bum Park, Hyunwook Kang, et al.
Journal for Immunotherapy of Cancer|February 26, 2025
Enhanced thrombopoiesis supplies PD-L1 to circulating immune cells via the generation of PD-L1-expressing platelets in patients with lung cancerSung-Woo Lee, Saei Jeong, Young Ju Kim, et al.
BMC Infectious Diseases|May 16, 2013
Pulmonary actinomycosis during the first decade of 21st century: cases of 94 patientsSo Ri Kim, Lae Young Jung, In-Jae Oh, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2013
Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapyShin Yup Lee, Hyo-Gyoung Kang, Seung Soo Yoo, et al.
Biochemical and Biophysical Research Communications|April 24, 2016
Hippo pathway effector YAP inhibition restores the sensitivity of EGFR-TKI in lung adenocarcinoma having primary or acquired EGFR-TKI resistanceJeong Eun Lee, Hee Sun Park, Dahye Lee, et al.
Pageof 19